XTL Biopharmaceutica Correlations

XTLB Stock  USD 0.92  0.02  2.13%   
The current 90-days correlation between XTL Biopharmaceuticals and Avalo Therapeutics is 0.1 (i.e., Average diversification). The correlation of XTL Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

XTL Biopharmaceutica Correlation With Market

Average diversification

The correlation between XTL Biopharmaceuticals Ltd and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals Ltd and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Moving together with XTL Stock

  0.64INAB In8bio IncPairCorr
  0.65MAIA MAIA BiotechnologyPairCorr
  0.65PLRZ Polyrizon OrdinaryPairCorr

Moving against XTL Stock

  0.62603122 Cowealth Medical ChinaPairCorr
  0.4UPB Upstream Bio,PairCorr
  0.39ZBIO Zenas BioPharma, CommonPairCorr
  0.32ERNA Eterna TherapeuticsPairCorr
  0.31ZYME Zymeworks Common StockPairCorr
  0.68REGN Regeneron PharmaceuticalsPairCorr
  0.54688670 Jiangsu GDK BiotechnologyPairCorr
  0.53PYPD PolyPidPairCorr
  0.5CIZ Cizzle BiotechnologyPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AVTXIVVD
IMDXAVTX
TARAPLX
TARAAVTX
TARAIVVD
IMDXIVVD
  

High negative correlations

IMDXCDXS
TARACCCC
SGMOCCCC
CCCCPLX
IMDXOABI
AVTXOABI

Risk-Adjusted Indicators

There is a big difference between XTL Stock performing well and XTL Biopharmaceutica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze XTL Biopharmaceutica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
OABI  2.90 (0.46) 0.00 (0.13) 0.00 
 6.21 
 17.86 
IVVD  8.56  2.36  0.28  4.72  6.97 
 16.26 
 99.46 
SLS  3.18 (0.13) 0.00 (0.04) 0.00 
 7.30 
 18.01 
CDXS  3.17 (1.06) 0.00 (0.29) 0.00 
 5.91 
 25.89 
AVTX  4.11  0.77  0.22  0.36  3.52 
 14.17 
 30.02 
PLX  3.74  0.27  0.04  0.44  5.44 
 7.00 
 31.36 
CCCC  4.29  0.16  0.04  0.16  4.80 
 9.90 
 51.62 
IMDX  4.32  1.69  0.46  0.75  2.60 
 12.36 
 21.90 
SGMO  3.54 (0.33) 0.00 (0.11) 0.00 
 7.41 
 28.86 
TARA  3.60  0.84  0.27  0.59  2.76 
 13.97 
 26.91 

XTL Biopharmaceutica Corporate Management

Itay CPAChief OfficerProfile
Itay WeinsteinChief OfficerProfile
Noam BandChief OfficerProfile
Shlomo ShalevCEO DirectorProfile
Ronen KantorCompany SecProfile